COVID-19: CDC, FDA and CMS Guidance

This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.

Jan 19, 2023
In an online survey last November of 1,200 U.S. adults previously vaccinated against COVID-19, 62% had not yet received a bivalent booster dose, most often because they did not know they were eligible or the booster was available, or believed they were immune against infection.
Oct 10, 2022
During the COVID-19 public health emergency, CMS will continue to exercise enforcement discretion under the Clinical Laboratory Improvement Amendments to allow providers to test asymptomatic individuals using certain point-of-care SARS-CoV-2 tests authorized for symptomatic individuals, CMS…
Sep 27, 2022
The Centers for Disease Control and Prevention Friday, Sept. 23 released updates to certain COVID-19 guidance pertaining to health care providers.
Sep 26, 2022
The Centers for Disease Control and Prevention Friday updated its COVID-19 infection control guidance for U.S. health care settings based on current information. The guidance updates the circumstances when source control (respirator and face mask use) and universal personal protective equipment are…
Aug 17, 2022
The Department of Health and Human Services (HHS) has announced that the Centers for Disease Control and Prevention (CDC) will assume responsibility for the collection of hospital COVID-19 data, beginning in mid-December 2022.
Aug 12, 2022
The Food and Drug Administration yesterday advised people who get a negative result from an at-home COVID-19 antigen test to test themselves again after 48 hours to reduce the risk of missing an infection and spreading the virus to others.
Aug 11, 2022
The CDC released updated guidance to help people protect themselves and others if they are exposed to, sick or test positive for COVID-19.   
Jul 8, 2022
The FDA granted full approval of Pfizer’s COVID-19 vaccine for young teens, covering the age group spanning 12 to 15 years old
Jul 6, 2022
The FDA authorized state-licensed pharmacists to prescribe Paxlovid to patients as a treatment for those at high risk of severe COVID-19.